A Rapkin

Summary

Affiliation: University of California
Country: USA

Publications

  1. doi request reprint Premenstrual dysphoric disorder and severe premenstrual syndrome in adolescents
    Andrea J Rapkin
    Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, University of California Los Angeles, 10833 Le Conte Avenue, Room 27 139 CHS, Los Angeles, CA 90095 1740, USA
    Paediatr Drugs 15:191-202. 2013
  2. doi request reprint Pathophysiology of premenstrual syndrome and premenstrual dysphoric disorder
    Andrea J Rapkin
    Department of Obstetrics and Gynecology, David Geffen School of Medicine, UCLA, Los Angeles, CA 90095, USA
    Menopause Int 18:52-9. 2012
  3. pmc Neuroactive steroids after estrogen exposure in depressed postmenopausal women treated with sertraline and asymptomatic postmenopausal women
    Melinda L Morgan
    Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, 10833 Le Conte Avenue, Los Angeles, CA 90095 1740, USA
    Arch Womens Ment Health 13:91-8. 2010
  4. ncbi request reprint Vasomotor symptoms in menopause: physiologic condition and central nervous system approaches to treatment
    Andrea J Rapkin
    Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095 1740, USA
    Am J Obstet Gynecol 196:97-106. 2007
  5. ncbi request reprint Drospirenone: a novel progestin
    Andrea J Rapkin
    Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095 1740, USA
    Expert Opin Pharmacother 8:989-99. 2007
  6. ncbi request reprint The pharmacologic management of premenstrual dysphoric disorder
    Andrea J Rapkin
    Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, 10833 Le Conte Avenue, Los Angeles, California 90095 1740, USA
    Expert Opin Pharmacother 9:429-45. 2008
  7. doi request reprint Drospirenone/ethinyl estradiol
    Andrea J Rapkin
    Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California, Los Angeles, California, USA
    Drugs Today (Barc) 44:133-45. 2008
  8. doi request reprint Premenstrual syndrome and premenstrual dysphoric disorder in adolescents
    Andrea J Rapkin
    Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, Los Angeles, California 90095 1740, USA
    Curr Opin Obstet Gynecol 20:455-63. 2008
  9. ncbi request reprint YAZ in the treatment of premenstrual dysphoric disorder
    Andrea J Rapkin
    Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, Center for Health Sciences, 10833 Le Conte Avenue, Los Angeles, CA 90095 1740, USA
    J Reprod Med 53:729-41. 2008
  10. doi request reprint Premenstrual syndrome and premenstrual dysphoric disorder: quality of life and burden of illness
    Andrea J Rapkin
    Professor of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA
    Expert Rev Pharmacoecon Outcomes Res 9:157-70. 2009

Detail Information

Publications29

  1. doi request reprint Premenstrual dysphoric disorder and severe premenstrual syndrome in adolescents
    Andrea J Rapkin
    Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, University of California Los Angeles, 10833 Le Conte Avenue, Room 27 139 CHS, Los Angeles, CA 90095 1740, USA
    Paediatr Drugs 15:191-202. 2013
    ..Serotonergic agonists are a first-line therapy for adults, and some serotonin reuptake inhibitors such as fluoxetine and escitalopram can be administered safely to teens...
  2. doi request reprint Pathophysiology of premenstrual syndrome and premenstrual dysphoric disorder
    Andrea J Rapkin
    Department of Obstetrics and Gynecology, David Geffen School of Medicine, UCLA, Los Angeles, CA 90095, USA
    Menopause Int 18:52-9. 2012
    ..Brain imaging studies have begun to shed light on the complex brain circuitry underlying affect and behaviour and may help to explicate the intricate neurophysiological foundation of the syndrome...
  3. pmc Neuroactive steroids after estrogen exposure in depressed postmenopausal women treated with sertraline and asymptomatic postmenopausal women
    Melinda L Morgan
    Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, 10833 Le Conte Avenue, Los Angeles, CA 90095 1740, USA
    Arch Womens Ment Health 13:91-8. 2010
    ..Estradiol exposure did not alter ALLO, DHEA, or THDOC, implying these NAS are unlikely to play a role in any mood changes in post menopausal women given estrogen therapy...
  4. ncbi request reprint Vasomotor symptoms in menopause: physiologic condition and central nervous system approaches to treatment
    Andrea J Rapkin
    Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095 1740, USA
    Am J Obstet Gynecol 196:97-106. 2007
    ..Most notable among these are vasomotor symptoms (hot flashes and night sweats) and mood and sleep disturbances...
  5. ncbi request reprint Drospirenone: a novel progestin
    Andrea J Rapkin
    Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095 1740, USA
    Expert Opin Pharmacother 8:989-99. 2007
    ....
  6. ncbi request reprint The pharmacologic management of premenstrual dysphoric disorder
    Andrea J Rapkin
    Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, 10833 Le Conte Avenue, Los Angeles, California 90095 1740, USA
    Expert Opin Pharmacother 9:429-45. 2008
    ....
  7. doi request reprint Drospirenone/ethinyl estradiol
    Andrea J Rapkin
    Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California, Los Angeles, California, USA
    Drugs Today (Barc) 44:133-45. 2008
    ..It has received U.S. Food and Drug Administration (FDA) indications not only for the prevention of pregnancy but also for PMDD and for moderate acne vulgaris in women who choose oral contraception for birth control (4, 5)...
  8. doi request reprint Premenstrual syndrome and premenstrual dysphoric disorder in adolescents
    Andrea J Rapkin
    Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, Los Angeles, California 90095 1740, USA
    Curr Opin Obstet Gynecol 20:455-63. 2008
    ..To review the current knowledge about the prevalence, diagnosis, and management of premenstrual syndromes in adolescents...
  9. ncbi request reprint YAZ in the treatment of premenstrual dysphoric disorder
    Andrea J Rapkin
    Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, Center for Health Sciences, 10833 Le Conte Avenue, Los Angeles, CA 90095 1740, USA
    J Reprod Med 53:729-41. 2008
    ....
  10. doi request reprint Premenstrual syndrome and premenstrual dysphoric disorder: quality of life and burden of illness
    Andrea J Rapkin
    Professor of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA
    Expert Rev Pharmacoecon Outcomes Res 9:157-70. 2009
    ..This review will focus on the epidemiology, diagnosis, treatment outcomes, quality of life and burden of illness for premenstrual disorders...
  11. ncbi request reprint Ethinyl estradiol/drospirenone for the treatment of the emotional and physical symptoms of premenstrual dysphoric disorder
    Andrea J Rapkin
    David Geffen School of Medicine at UCLA, Department of Obstetrics and Gynecology, 10833 Le Conte Avenue, Los Angeles, CA 90095 1740, USA
    Womens Health (Lond Engl) 3:395-408. 2007
    ....
  12. pmc Neuroimaging evidence of cerebellar involvement in premenstrual dysphoric disorder
    Andrea J Rapkin
    Department of Obstetrics and Gynecology, David Geffen School of Medicine at University of California at Los Angeles, Los Angeles, California 90095 1740, USA
    Biol Psychiatry 69:374-80. 2011
    ..Despite a prevalence of up to 8% in women of reproductive age, few studies have investigated the brain mechanisms that underlie this disorder...
  13. ncbi request reprint Peritoneal fluid interleukin-6 in women with chronic pelvic pain
    A Rapkin
    Department of Obstetrics and Gynecology, UCLA School of Medicine, Los Angeles, California 90095 1740, USA
    Fertil Steril 74:325-8. 2000
    ..To determine the relationship between peritoneal fluid concentrations of interleukin-6 (IL-6) and chronic pelvic pain symptomatology in women with adhesions, endometriosis, or no obvious intraperitoneal pathology...
  14. ncbi request reprint New treatment approaches for premenstrual disorders
    Andrea J Rapkin
    Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095 1740, USA
    Am J Manag Care 11:S480-91. 2005
    ..New pharmacologic research is promising and is discussed along with the need to provide empathetic counseling for patients to determine the approach that will work best for each individual...
  15. ncbi request reprint The clinical nature and formal diagnosis of premenstrual, postpartum, and perimenopausal affective disorders
    Andrea J Rapkin
    Department of Obstetrics and Gynecology, University of California, Los Angeles Medical Center, Box 951740, 27 139 CHS, Los Angeles, CA 90095, USA
    Curr Psychiatry Rep 4:419-28. 2002
    ..All of these disorders share risk factors, and have etiologic features in common, such as exposure to the rise and fall of ovarian sex steroids. The following is a review of these syndromes and their etiology, diagnosis, and treatment...
  16. ncbi request reprint A review of treatment of premenstrual syndrome and premenstrual dysphoric disorder
    Andrea Rapkin
    UCLA School of Medicine, Department of Obstetrics and Gynecology, Center for the Health Sciences, Los Angeles, CA 90095 1740, USA
    Psychoneuroendocrinology 28:39-53. 2003
    ..The studies are in progress, however, preliminary evidence suggests that the drospirenone-containing pill called Yasmin may be effective the treatment of PMDD...
  17. ncbi request reprint Relationships among self-rated tanner staging, hormones, and psychosocial factors in healthy female adolescents
    Andrea J Rapkin
    Department of Obstetrics and Gynecology, Los Angeles, California 90095, USA
    J Pediatr Adolesc Gynecol 19:181-7. 2006
    ..The purpose of the present study was to examine the associations among hormone concentrations, self-rated Tanner staging and dysmenorrhea, and to determine whether various psychosocial factors modulate these relationships...
  18. ncbi request reprint Premenstrual syndrome in adolescents: diagnosis and treatment
    Andrea J Rapkin
    Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA
    Pediatr Endocrinol Rev 3:132-7. 2006
    ..In adolescents, treatment should begin with education and lifestyle changes; however, many of the treatments used commonly in adults can also be employed safely in severe adolescent cases...
  19. ncbi request reprint Decreased neuroactive steroids induced by combined oral contraceptive pills are not associated with mood changes
    Andrea J Rapkin
    Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California 90095 1740, USA
    Fertil Steril 85:1371-8. 2006
    ..These neuroactive steroids are gamma-aminobutyric acid receptor agonists and are important in the modulation of affect and adaptation to stress...
  20. ncbi request reprint Estrogen replacement therapy in the treatment of major depressive disorder in perimenopausal women
    Natalie L Rasgon
    Department of Psychiatry and Biobehavioral Science, University of California, Los Angeles, USA
    J Clin Psychiatry 63:45-8. 2002
    ..Fluctuating estrogen levels accompany the perimenopausal transition. Thus, estrogen replacement therapy (ERT) has been proposed as a potentially effective treatment for mood disorders occurring during perimenopause...
  21. ncbi request reprint Gynecological health of females with congenital heart disease
    Mary M Canobbio
    Ahmanson UCLA Center for Adult Congenital Heart Disease, UCLA School of Nursing, Box 951702, Los Angeles, CA 90095, USA
    Int J Cardiol 98:379-87. 2005
    ..Contraceptives must be selected according to individual patient profiles. Hormone replacement therapy is warranted for relief of menopausal symptoms as in the general population and should be relatively safe because estrogen dose is low...
  22. ncbi request reprint Estrogen augmentation of antidepressants in perimenopausal depression: a pilot study
    Melinda L Morgan
    Laboratory of Behavioral Pharmacology, University of California Los Angeles Neuropsychiatric Institute and Hospital, Department of Psychiatry and Biobehavioral Sciences, 90024, USA
    J Clin Psychiatry 66:774-80. 2005
    ..To investigate the effects of estrogen augmentation on mood and memory in women with perimenopausal depression who had experienced a partial response to antidepressant medications...
  23. ncbi request reprint Neurophysiologic changes during estrogen augmentation in perimenopausal depression
    Melinda L Morgan
    Laboratory of Brain, Behavior, and Pharmacology, Department of Psychiatry and Biobehavioral Sciences, UCLA Neuropsychiatric Institute, 760 Westwood Plaza, Suite 37 439, Los Angeles, CA 90024 1759, United States
    Maturitas 56:54-60. 2007
    ..We also assessed whether such changes were correlated with serum hormone levels...
  24. ncbi request reprint Premenstrual disorders: prevalence, etiology and impact
    Sharon A Winer
    Department of Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, 9400 Brighten Way, Suite 206, Beverly Hills, CA 90210, USA
    J Reprod Med 51:339-47. 2006
    ..Premenstrual disorders can have a significant negative impact on a woman's quality of life and work productivity...
  25. ncbi request reprint Oral contraceptives and neuroactive steroids
    Andrea J Rapkin
    Department of Obstetrics and Gynecology, David Geffen School of Medicine, UCLA, Los Angeles, CA, United States
    Pharmacol Biochem Behav 84:628-34. 2006
    ....
  26. ncbi request reprint Neuroactive steroid-serotonergic interaction: responses to an intravenous L-tryptophan challenge in women with premenstrual syndrome
    N Rasgon
    Department of Psychiatry and Biobehavioral Sciences, Neuropsychiatric Institute, UCLA School of Medicine, Los Angeles, California 90095, USA
    Eur J Endocrinol 145:25-33. 2001
    ..Women with PMS demonstrated a more significant increase in allopregnanolone concentrations in response to L-TP challenge, which could be due to an initial low basal serotonergic tone in the luteal phase in the PMS group...
  27. ncbi request reprint Multilevel local anesthetic nerve blockade for the treatment of vulvar vestibulitis syndrome
    Andrea J Rapkin
    Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA Los Angeles, CA, USA
    Am J Obstet Gynecol 198:41.e1-5. 2008
    ..Vulvar vestibulitis syndrome is a major cause of dyspareunia. This pilot study was designed to evaluate a novel treatment approach...
  28. ncbi request reprint Diagnosis of premenstrual disorders
    Lori A Futterman
    San Diego Premenstrual Syndrome Clinic, Department of Psychiatry, University of California San Diego, 591 Camino de la Reina, Suite 705, San Diego, CA 92108, USA
    J Reprod Med 51:349-58. 2006
    ..Many women with a bothersome or debilitating premenstrual disorder go undiagnosed, either because they do not report their symptoms to a clinician or because the clinician has difficulty diagnosing the disorder...
  29. ncbi request reprint Treatment of premenstrual disorders
    Robin Kroll
    Women s Clinical Research Center, Lakeview Medical Dental Building, 3216 NE 45th Place, Suite 1000, Seattle, WA 98105, USA
    J Reprod Med 51:359-70. 2006
    ..A new drospirenone-containing OC formulation that is administered for 24 days in a 28-day cycle has been shown to be effective in treating PMDD...